Endava PLC Sponsored ADR (NYSE:DAVA - Get Free Report) has received an average recommendation of "Reduce" from the nine analysts that are presently covering the firm, MarketBeat reports. Three analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $5.36.
Several research analysts have recently weighed in on DAVA shares. TD Cowen restated a "hold" rating and issued a $3.50 target price on shares of Endava in a research note on Tuesday, September 22nd. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Endava in a research note on Tuesday, September 8th. William Blair lowered shares of Endava from a "market perform" rating to an "underperform" rating in a report on Tuesday, September 22nd. Needham & Company LLC reiterated a "buy" rating and issued a $5.00 price objective on shares of Endava in a report on Monday, October 12th. Finally, Zacks Research raised shares of Endava from a "strong sell" rating to a "hold" rating in a research report on Monday, July 20th.
Read Our Latest Analysis on DAVA
Key Headlines Impacting Endava
Here are the key news stories impacting Endava this week:
- Neutral Sentiment: Multiple law firms, including Rosen Law Firm and Pomerantz, announced or promoted securities class-action claims involving investors who purchased Endava securities between September 4, 2025, and September 21, 2026. The lead-plaintiff deadline is November 30, 2026. Rosen Law Firm investor notice Pomerantz investor alert
- Negative Sentiment: The lawsuits allege that Endava made materially misleading statements or failed to disclose adverse information about its business, operations, and prospects. The claims relate to a roughly 25% share-price collapse on September 22 after disclosures involving delayed financial reporting, potential accounting problems, and serious management issues. Endava’s CFO was also reported to be on leave. These are allegations, not established findings. Endava class-action report
- Negative Sentiment: The repeated investor-law-firm notices increase visibility around Endava’s legal and governance risks, potentially adding pressure to the stock and maintaining uncertainty until the company clarifies its financial statements, accounting practices, management situation, and litigation exposure. Faruqi investor notice
Institutional Trading of Endava
An institutional investor recently raised its position in Endava stock. Barometer Capital Management Inc. boosted its holdings in Endava PLC Sponsored ADR (NYSE:DAVA - Free Report) by 32.5% in the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 106,300 shares of the company's stock after purchasing an additional 26,080 shares during the period. Barometer Capital Management Inc. owned about 0.19% of Endava worth $470,000 at the end of the most recent reporting period. 62.23% of the stock is currently owned by hedge funds and other institutional investors.
Endava Stock Up 6.1%
Shares of NYSE:DAVA opened at $2.18 on Wednesday. The company has a market capitalization of $122.31 million, a price-to-earnings ratio of -0.21 and a beta of 1.14. The company has a 50 day moving average of $2.58 and a two-hundred day moving average of $3.11. Endava has a 52-week low of $1.60 and a 52-week high of $9.88. The company has a quick ratio of 2.07, a current ratio of 2.07 and a debt-to-equity ratio of 1.13.
About Endava
(
Get Free Report)
Endava plc is a technology services company that helps organizations design, develop and modernize digital products, platforms and business operations. Its services include digital strategy, software engineering, cloud and enterprise technology, data and artificial intelligence, customer experience, and technology consulting.
The company works with clients across industries including payments and financial services, telecommunications, media and technology, mobility, healthcare, retail and consumer products.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Endava, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Endava wasn't on the list.
While Endava currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.